GM cuts thousands of EV jobs, citing slower adoption and regulatory changes, as it restructures operations to improve flexibility.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
AMD shares rise ahead of strong earnings forecast, outpacing sector and S&P 500
GM cuts thousands of EV jobs, citing slower adoption and regulatory changes, as it restructures operations to improve flexibility.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
AMD shares rise ahead of strong earnings forecast, outpacing sector and S&P 500